An Open Label Study to Evaluate the Contraceptive Efficacy and Safety of Norethindrone Acetate Transdermal Delivery System (Simplify).

Trial Profile

An Open Label Study to Evaluate the Contraceptive Efficacy and Safety of Norethindrone Acetate Transdermal Delivery System (Simplify).

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Sep 2013

At a glance

  • Drugs Norethisterone (Primary)
  • Indications Pregnancy
  • Focus Registrational; Therapeutic Use
  • Acronyms Simplify
  • Sponsors Actavis Inc
  • Most Recent Events

    • 01 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Jul 2011 Planned End Date changed from 1 Feb 2012 to 1 Mar 2012 as reported by ClinicalTrials.gov.
    • 05 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top